EUHA promotes excellence and innovation in healthcare, research and education for better health outcomes and sustainable European healthcare systems.
University hospitals play an essential role in society, taking care of the most complex patients, performing research and innovating treatments. At the same time, the next generation of healthcare professionals also trains in their hospitals. EUHA enables its members to share best practices, exchange professionals and collaborate in concrete projects with the aim to learn from each other and to leverage the joint capabilities to help shape healthcare of the future in Europe.
Vall d’Hebron Barcelona Hospital Campus is a world-class healthcare park where assistance, research, teaching and innovation go hand in hand. We are the sum of five institutions: Vall d’Hebron University Hospital, Vall d’Hebron Research Institute, Vall d’Hebron Institute of Oncology, the Multiple Sclerosis Center of Catalonia and the Autonomous Uiversity of Barcelona. We work together with the same pioneering spirit and a common goal: to improve the health and well-being of people.
The Vall d’Hebron University Hospital is the largest tertiary hospital group in Catalonia and one of the largest in Spain. We offer high-complexity healthcare from birth to old age.
With a total of 3,011 beds, Charité – Universitätsmedizin Berlin is one of the largest university hospitals in Europe. Charité spans 4 campuses and comprises approximately 100 Departments and Institutes. In 2016, Charité treated more than 146,000 inpatient and more than 694,000 outpatient cases. With approximately 17,100 staff employed across the Charité group of companies, Charité is one of the largest employers in Berlin. In 2016, the Charité university hospital recorded a turnover of €1.6 billion.
The areas of research, teaching, and health care delivery are intricately linked, resulting in a working relationship that is characterized by interdisciplinary cooperation. In 2016, Charité was able to secure more than €153 million in third-party funding, as well as approximately €203 million in state funding for research and teaching. With approximately 7,000 future physicians and dentists currently enrolled in degree courses, Charité is one of the largest medical faculties in Germany.
Erasmus MC is a University Medical Center that combines medical, nursing and post-graduate schools, biomedical research facilities, a tertiary care and teaching hospital and a general hospital. Erasmus MC research stretches from biomedical to patient and population based research. The institute has 4.500 (bio) medical students, 16.500 employees and an annual budget of approximately 1.7 billion euro. It is the largest university medical center in the Netherlands.
The institute aims to further expand its international activities in the coming years, both in terms of patient care and education, while already being strongly internationally oriented in research. Erasmus MC has 60 designated centers of expertise for rare diseases, approved by the Dutch government and 18 of them are involved in European Reference Networks as member, coordinator or sub-coordinator. The strategy of the Erasmus MC is to expand on tertiary and complex acute care, among others by creating a network with other hospitals.
Karolinska University Hospital is one of the largest university hospitals in Europe. We have a triple assignment of healthcare, research, and education, and a guiding vision – “Patient first”. We work closely with the Karolinska Institute, providing training and conducting world-class medical research in many different fields. Together, we are the hub of an academic healthcare system generating new and improved medical outcomes and accelerating the time to patient access of the benefits they bring.
Karolinska University Hospital is committed to and involved in a wide range of medical research that not only enhances and improves our existing knowledge, but also forms the basis for future health and medical care. Karolinska University Hospital’s new hospital building in Solna is one of the largest ever investments made in health and medical care in Sweden. The new facilities will also optimize the expertise and equipment at our disposal, enhancing our ability to take care of the most severely injured and seriously ill patients.
King’s Health Partners (KHP) is an Academic Health Sciences Centre where world-class research, education and clinical practice are brought together for the benefit of patients. KHP brings together three NHS Foundation Trusts with a world-leading university for health research and education. With nearly 4.8 million patient contacts each year, 46,000 staff and nearly 31,000 students and a combined annual turnover of more than £4.2 billion, KHP provides services across central and outer London locations, including seven mental health and physical healthcare hospitals and many community sites.
King’s College London is ranked in the top 25 research universities in the world. It is the largest centre for healthcare education in Europe, and provides education and research in the widest range of subjects allied to medicine of any London institution.
Our three NHS founders; Guy’s and St Thomas’, King’s College Hospital and South London and Maudsley NHS Foundation Trusts, serve a local population which is among the most ethnically, socially and economically diverse in the world. Together they provide a full range of medical and healthcare services, from acute and specialist medical care, local and highly specialised mental healthcare, and services that promote physical and psychological wellbeing.
IRCCS Ospedale San Raffaele is a university and research hospital established in 1971, capable of offering specialized care for the most complex medical conditions. In 1972, the hospital was officially recognized as a research hospital (Istituto di Ricovero e Cura a Carattere Scientifico, IRCCS), and in 2012 it became part of Gruppo San Donato.
With over 60 clinical units and 100 research laboratories, IRCCS Ospedale San Raffaele combines both clinical and scientific activities through a translational approach whereby discoveries made in the laboratory inform clinical practice and research is driven by clinical needs.
The institute aims at understanding the mechanisms underlying a variety of human diseases and at identifying new therapeutic strategies to treat them. Alongside with improving therapies, the institute aims to develop new technologies in the field of genomics and imaging, essential for supporting early diagnosis and increasingly personalized medicine. Among the principal clinical area of investigation: central and peripheral nervous systems pathologies, tumors, immune-mediated, infectious, genetic, cardiovascular and metabolic diseases. The institute is recognized as a global authority in cell and gene therapies.
With the University Hospital Vienna (AKH Vienna) and the Medical University of Vienna (MedUni Vienna), two outstanding institutions are concentrated at one location. The University Hospital Vienna is ranked among the best hospitals in the world. The Medical University of Vienna is one of the most longstanding medical training and research facilities in Europe. Together, the two institutions fulfill three core tasks: Patient care, research and teaching. At 29 clinical departments with over 400 specialized outpatient departments, a broad spectrum of medical expertise is available. New therapies are constantly being established and implemented in numerous highly specialized departments.
The AKH Vienna and the MedUni Vienna form together the largest and most important medical care center in Austria in which more than 60,000 patients are treated annually as in-patients. The out-patient and special out-patient wards are frequented by around further 1.2 million people. Each year, around 45,000 operations are carried out at the University Hospital Vienna. With almost 8,000 students, the MedUni Vienna is currently the largest medical training centre in the German-speaking countries.
As the largest university hospital in Belgium, UH Leuven wants to break new ground by combining specialised care and innovative treatments with personal attention and respect for every patient. More than 10, 000 passionate employees provide the best personalised care every day. Future care providers and employees receive high-quality training at UH Leuven, with a view to life-long learning and innovating. A pioneer in clinical trials, the hospital also invests in patient care of tomorrow
Through constant investment in research, new treatments and the latest technology, UH Leuven is among the Belgian and international top in many disciplines. Patients with the most complex conditions come to UH Leuven. The hospital is renowned worldwide for transplants, foetal surgery, the centre for human genetics, hereditary diseases and has the first Belgian proton therapy centre for cancer treatments and investigation. The hospital is located on the Gasthuisberg Health Sciences campus, where hospital physicians and university researchers work within walking distance from one another. The combination of clinical care, research and education in a single location creates an inspiring interaction that, ultimately, always has one goal in mind: better patient care.